PIK3CA and breast carcinoma: PIK3CA mutation is the most common alteration of this pathway linked to breast cancer, with ≥80% of mutations occurring within the helical (E542K and E545K) and kinase (H1047R) domains of p110α [1,[4], [5], [6]].